Detalhe da pesquisa
1.
The Effect of Previous Exposure to Malaria Infection and Clinical Malaria Episodes on the Immune Response to the Two-Dose Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen.
Vaccines (Basel)
; 11(8)2023 Aug 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37631885
2.
Safety and immunogenicity of an Ad26.ZEBOV booster dose in children previously vaccinated with the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen: an open-label, non-randomised, phase 2 trial.
Lancet Infect Dis
; 23(3): 352-360, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36273490